Development of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues

What are the regulatory challenges for testing and introducing investigative TB vaccines into countries where the disease is endemic?

• Publication year

  2007

• Venue

  PLoS Medicine

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pmed.0040252PMID 17683198PMCID 1939860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.

  2006cited by this paper
• The development and impact of tuberculosis vaccines.

  2006cited by this paper
• Advances in tuberculosis vaccine strategies

  2006cited by this paper
• Annex 1 WHO guidelines on nonclinical evaluation of vaccines

  2005cited by this paper
• Prime-boost immunisation strategies for tuberculosis.

  2005cited by this paper
• Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis.

  2005cited by this paper
• The tuberculosis vaccine challenge.

  2005cited by this paper
• New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development.

  2005cited by this paper
• Advancing TB vaccines to Phase I clinical trials in the US: regulatory/manufacturing/licensing issues.

  2005cited by this paper
• TB subunit vaccines--putting the pieces together.

  2005cited by this paper
• Prospects for new TB vaccines: Stop TB Working Group on TB Vaccine Development.

  2004cited by this paper
• Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein1

  2004cited by this paper
• Tuberculosis vaccine development: research, regulatory and clinical strategies

  2004cited by this paper
• Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

  2004cited by this paper
• Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

  2003cited by this paper
• Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6

  2001cited by this paper
• An essential role for phoP in Mycobacterium tuberculosis virulence

  2001cited by this paper
• Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.

  2000cited by this paper
• Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes.

  1998cited by this paper

• Still Standing Strong: A Narrative Review of Why BCG Remains Central to Global Tuberculosis Control

  2025cites this paper
• Shared challenges to the control of complex intracellular neglected pathogens

  2024cites this paper
• What impact do the current anti-vaccine movementsand the Covid-19 pandemic have on the vaccination coverage of Poles? Statistical analysis of epidemiological data on the level of vaccination of Poles in the years 2001-2020

  2022cites this paper
• Qualitative formative implementation research to inform introduction of a new essential medicine.

  2020cites this paper
• Current Advances in the Development of Drug and Vaccine for Tuberculosis Prevention and Treatment

  2020cites this paper
• CHAPTER 13

  2019cites this paper
• Facteurs influençant la régulation des essais cliniques au Mali

  2017cites this paper
• TB Vaccine Assessment

  2016cites this paper
• Incidence of tuberculosis among school-going adolescents in South India

  2016cites this paper
• Enfermedades Infecciosas y Microbiología Clínica

  2016cites this paper
• Vaccine Preparation: Past, Present, and Future

  2016cites this paper
• Genes del Mycobacterium tuberculosis involucrados en la patogenicidad y resistencia a antibióticos durante la tuberculosis pulmonar y extrapulmonar

  2015cites this paper
• Mycobacterium tuberculosis Surface-binding Antibodies Influence Early Infection Events

  2015cites this paper
• PRECLINICAL EVALUATION OF TB VACCINES

  2014cites this paper
• Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: a discussion of the adaptive licensure concept.

  2014cites this paper
• ATTENUATED VACCINES

  2014cites this paper
• The tuberculin skin test in school going adolescents in South India: associations of socio-demographic and clinical characteristics with TST positivity and non-response

  2014cites this paper
• Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation

  2014cites this paper
• In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis

  2014cites this paper
• Helping each other regulate clinical trials: a network of vaccine regulators from developing countries

  2013cites this paper
• Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis.

  2013cites this paper
• Product Registration in Developing Countries: A Proposal for an Integrated Regional Licensing System Among Countries in Regional Economic Blocs

  2013cites this paper
• Implementing new health interventions in developing countries: why do we lose a decade or more?

  2012cites this paper
• Microbiological and immunological diagnosis of tuberculous spondylodiscitis.

  2012cites this paper
• Key issues in the clinical development and implementation of TB vaccines in South Africa.

  2012cites this paper
• Mycobacterium tuberculosis Vaccination Imprints on T-Cell Dynamics Associated with Mycobacterium tuberculosis Challenge in Rhesus Monkeys

  2012cites this paper
• The Long Term Effect of Current and New Interventions on the New Case Detection of Leprosy: A Modeling Study

  2011cites this paper
• New tuberculosis vaccines.

  2011cites this paper
• Present epidemiology of tuberculosis. Prevention and control programs.

  2011cites this paper
• Evidence and guidance on vaccine safety and effectiveness in subpopulations

  2011cites this paper
• Dengue Vaccines Regulatory Pathways: A Report on Two Meetings with Regulators of Developing Countries

  2011cites this paper
• Tuberculosis vaccines in clinical trials

  2011cites this paper
• Immune intervention strategies against tuberculosis

  2011cites this paper
• Publics and Vaccinomics: Beyond Public Understanding of Science

  2011cites this paper
• Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.

  2010cites this paper
• The second Geneva Consensus: Recommendations for novel live TB vaccines.

  2010cites this paper
• Tuberculosis 6 New vaccines for tuberculosis

  2010cites this paper
• New vaccines for tuberculosis.

  2010cites this paper
• Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis

  2010cites this paper
• Respiratory Mucosal Immunization against Pulmonary Tuberculosis

  2010cites this paper
• Preclinical Evaluation of Tuberculosis Vaccines

  2010cites this paper
• Surface Expression of MPT64 as a Fusion with the PE Domain of PE_PGRS33 Enhances Mycobacterium bovis BCG Protective Activity against Mycobacterium tuberculosis in Mice

  2010cites this paper
• A New Vaccine for Tuberculosis: The Challenges of Development and Deployment

  2009cites this paper
• Joint reviews and inspections: strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa.

  2009cites this paper
• Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development.

  2009cites this paper
• The quest for a new vaccine against tuberculosis.

  2009cites this paper
• egulatory oversight of clinical trials in Africa: Progress over the past 5 years

  2009cites this paper
• The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases

  2009cites this paper
• Regulatory oversight of clinical trials in Africa: progress over the past 5 years.

  2009cites this paper
• Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis

  2009cites this paper
• Rapport de Stage à l'Organisation Mondiale de la Santé (du 15 juin au 7 août 2009 à Genève)

  2009influential citation
• Need for more TB vaccine field sites.

  2009cites this paper
• Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials

  2008cites this paper
• Mucosal vaccination against bacterial respiratory infections

  2008cites this paper
• Tuberculosis: vaccines in the pipeline

  2008cites this paper
• Attenuated strains of Mycobacterium tuberculosis complex for laboratory and clinical use.

  2008cites this paper
• Regulatory System Opportunities and Barriers for Conducting Clinical Trials in Ethiopia: A Descriptive Qualitative Study

  year unknowncites this paper